TrialAnnals of the rheumatic diseases2014

Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24.

David Saadoun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.